Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.2
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2020
Stockholders' Equity (Tables) [Line Items]  
Schedule of warrant and stock option grants
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-average exercise price per share     Number of shares subject to options     Weighted-average exercise price per share     Number of shares subject to restricted stock units     Weighted-average exercise price per share  
Balance at December 31, 2019     1,311,916     $ 9.35       338,595     $ 5.96       630,303     $           -  
Granted     -       -       -       -       395,000       -  
Exercised     -       -       -       -       -       -  
Cancelled/Forfeited     -       -       -       -       (250,000 )     -  
Balance at March 31, 2020     1,311,916     $ 9.35       338,595     $ 5.96       775,303     $ -  
Exercisable at March 31, 2020     1,311,916     $ 9.35       338,595     $ 5.96      

41,667

     $ -  
Schedule of stock-based compensation expense categorized of equity components
    For the three months ended  
    March 31,  
    2020     2019  
Common stock   $ 367,600     $ 257,885  
Stock option awards     -       49,018  
Transfer of common stock by founders to contractors     -       5,322,930  
Total   $ 367,600     $ 5,629,833  
Stock Options [Member]  
Stockholders' Equity (Tables) [Line Items]  
Schedule of stock-based compensation expense
    For the three months ended  
    March 31,  
    2020     2019  
Stock-based compensation expense   $ 367,600     $ 5,629,833